Business Combination - Summary of Fair Value of Purchase Consideration Transferred (Detail) - AxoBio [Member] |
Aug. 09, 2023
USD ($)
|
---|---|
Business Acquisition [Line Items] | |
Earnout | $ 13,482,292 |
Deferred Consideration | 8,000,000 |
Total estimated value of consideration transferred | 43,135,082 |
Series A Convertible Voting Preferred Stock [Member] | |
Business Acquisition [Line Items] | |
Shares issued | 10,382,107 |
Common Stock [Member] | |
Business Acquisition [Line Items] | |
Shares issued | $ 11,270,683 |
X | ||||||||||
- Definition Business combination, contingent earn-out. No definition available.
|
X | ||||||||||
- Definition Business combination, deferred consideration. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|